Brief: Stenocare Reports On Progress In Development Of New Product
02/06/2023 12:05
June 2 (Reuters) - Stenocare A/S STENO.CO :
* REPORTS ON SIGNIFICANT PROGRESS IN DEVELOPMENT OF ITS NEW
INNOVATIVE MEDICAL CANNABIS PRODUCT
* PRODUCT IN SIGHT THIS YEAR: NOW, STENOCARE HAS CHOSEN AN
EXPERIENCED PARTNER TO PRODUCE FIRST PILOT PRODUCT
* FOR CONFIDENTIALITY NAME OF PARTNER IS NOT DISCLOSED
* THIS WORK HAS SEVERAL STAGES, INCLUDING QUALIFICATION OF
INGREDIENCIES, TECHNICAL PRODUCTS TEST RUNS, EXTERNAL LAB
ANALYSIS AND STABILITY STUDIES
* IT IS AMBITION TO HAVE FIRST FINAL PRODUCT CANDIDATE READY
FOR
BEGINNING REGULATORY APPROVAL PROCESS BY END OF 2023
* THIS IMPLIES THAT PRODUCT IS LIKELY TO BECOME COMMERCIALLY
AVAILABLE DURING 2024
Source text for Eikon: ID:nWkr3BctLf
Further company coverage: STENO.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))